Veit J. Scheble
Impact in
- Oncology top 5%
- Cancer Cells and Metastasis
- Lung Cancer Research Studies
-
- Prostate Cancer Treatment and Research
- Lung Cancer Treatments and Mutations
Papers in
-
- Prostate Cancer Treatment and Research 12
- Lung Cancer Treatments and Mutations 3
- Oncology 6
- Lung Cancer Research Studies 3
- Cancer Cells and Metastasis 2
- Cancer Immunotherapy and Biomarkers 1
- Co-authors
- Sven Perner (20 shared papers)Falko Fend (17 shared papers)Karen Petersen (8 shared papers)Glen Kristiansen (9 shared papers)Mark A. Rubin (7 shared papers)Theresia Wilbertz (6 shared papers)Markus Reischl (6 shared papers)Annette Staebler (4 shared papers)
- Journals
- Modern Pathology (3 papers)Human Pathology (2 papers)Histopathology (2 papers)Prostate Cancer and Prostatic Diseases (2 papers)The Journal of Pathology (1 paper)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Veit J. Scheble
31 papers receiving 1.9k citations
Veit J. Scheble's Hit Papers
Peers
Comparison fields: 5 of 67
- Oncology 554
- Pulmonary and Respiratory Medicine 678
- Otorhinolaryngology 102
- Cancer Research 217
- Molecular Biology 438
Countries citing papers authored by Veit J. Scheble
This map shows the geographic impact of Veit J. Scheble's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Veit J. Scheble with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Veit J. Scheble more than expected).
Fields of papers citing papers by Veit J. Scheble
This network shows the impact of papers produced by Veit J. Scheble. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Veit J. Scheble. The network helps show where Veit J. Scheble may publish in the future.
Co-authors
The 25 scholars most cited alongside Veit J. Scheble, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas Hit paper breakdown → | 2009 | 800 |
| 2 | 2011 | 169 | |
| 3 | 2011 | 168 | |
| 4 | 2010 | 131 | |
| 5 | 2010 | 104 | |
| 6 | 2011 | 100 | |
| 7 | 2012 | 70 | |
| 8 | 2007 | 60 | |
| 9 | 2010 | 52 | |
| 10 | 2012 | 46 | |
| 11 | 2018 | 39 | |
| 12 | 2011 | 38 | |
| 13 | 2013 | 37 | |
| 14 | 2011 | 34 | |
| 15 | 2013 | 32 | |
| 16 | 2014 | 19 | |
| 17 | 2012 | 17 | |
| 18 | 2021 | 13 | |
| 19 | 2012 | 12 | |
| 20 | 2012 | 7 |
About Veit J. Scheble
Veit J. Scheble is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Hepatology, Cancer Research and Immunology, having authored 33 papers that have together received 2k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (12 papers), Lung Cancer Treatments and Mutations (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Lung Cancer Research Studies (3 papers), Cancer Cells and Metastasis (2 papers), Immunotherapy and Immune Responses (2 papers), Telemedicine and Telehealth Implementation (1 paper) and Cancer Immunotherapy and Biomarkers (1 paper). The work is most often cited by research in Oncology (554 citations), Pulmonary and Respiratory Medicine (678 citations), Otorhinolaryngology (102 citations), Cancer Research (217 citations) and Molecular Biology (438 citations). Veit J. Scheble has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Sven Perner, Falko Fend, Karen Petersen, Glen Kristiansen, Mark A. Rubin, Theresia Wilbertz, Markus Reischl, Annette Staebler, Claudia Lengerke and Martin Braun. Their work appears in journals such as Modern Pathology, Human Pathology, Histopathology, Prostate Cancer and Prostatic Diseases and The Journal of Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.